Depakote er and Levaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Depakote er (divalproex sodium) and Levaquin (levofloxacin). Common drug interactions include pain in extremity among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Depakote er and Levaquin. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Depakote er?

Depakote er has active ingredients of divalproex sodium. It is often used in bipolar disorder. eHealthMe is studying from 6,042 Depakote er users. Check the latest studies of Depakote er.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.



On Jul, 27, 2026

21 people who take Depakote er and Levaquin together, and have interactions are studied.

Depakote er and Levaquin drug interactions.

What are the common drug interactions of Depakote Er and Levaquin, by gender? *:

female:

  1. Pain in extremity
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Abdominal pain upper
  4. Asthenia (weakness)
  5. Dehydration (dryness resulting from the removal of water)
  6. Dyspepsia (indigestion)
  7. Gait disturbance
  8. Haematemesis (vomiting of blood)
  9. Nausea (feeling of having an urge to vomit)
  10. Oedema peripheral (superficial swelling)

male:

  1. Anxiety
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Granulocytopenia (lack of granulocyte)

What are the common drug interactions of Depakote Er and Levaquin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cholecystitis chronic (long lasting infection of gallbladder)
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Vomiting
  4. Abdominal pain upper
  5. Dyspepsia (indigestion)
  6. Haematemesis (vomiting of blood)
  7. Arthralgia (joint pain)
  8. Back pain
  9. Bone pain
  10. Cystitis (inflammation of the wall of the bladder)

30-39:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Pancreatitis (inflammation of pancreas)
  4. Type 2 diabetes mellitus

40-49:

  1. Anxiety
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Accident
  5. Blood cholesterol increased
  6. Blood triglycerides increased
  7. Hyperglycaemia (high blood sugar)
  8. Insulin resistance
  9. Irritable bowel syndrome
  10. Obesity (having too much body fat)

50-59:

  1. Dehydration (dryness resulting from the removal of water)
  2. Diarrhoea
  3. Drug ineffective
  4. Dyspnoea (difficult or laboured respiration)
  5. Emotional disorder
  6. Fatigue (feeling of tiredness)
  7. Gait disturbance
  8. Haematochezia (passage of stools containing blood)
  9. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  10. Hallucination (an experience involving the perception of something not present)

60+:

  1. Abnormal behaviour
  2. Confusional state
  3. Fall
  4. Haematoma (collection of blood outside the blood vessels)
  5. International normalised ratio increased
  6. Upper limb fracture

What are the existing conditions these people have? *

  1. Pain: 9 people, 42.86%
  2. Birth Control: 6 people, 28.57%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 14.29%
  4. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 9.52%
  5. Pneumonia: 2 people, 9.52%
  6. Nausea (feeling of having an urge to vomit): 2 people, 9.52%
  7. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 9.52%
  8. Depression: 2 people, 9.52%
  9. Back Pain: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Depakote er and Levaquin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Depakote er and Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Depakote er:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Depakote er and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on divalproex sodium and levofloxacin (the active ingredients of Depakote er and Levaquin, respectively), and Depakote er and Levaquin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: